Breaking News Instant updates and real-time market news.

NVCR

Novocure

$33.10

-0.25 (-0.75%)

08:18
07/16/18
07/16
08:18
07/16/18
08:18

Novocure initiated with an Outperform at Evercore ISI

Evercore ISI analyst Vijay Kumar initiated Novocure with an Outperform and $46 price target. Kumra believes Novocure is at an inflection point with the full data-set of mesothelioma expected in 2H 2018 and sees a potential big catalyst in 2019 with receipt of reimbursement from CMS.

  • 26

    Jul

NVCR Novocure
$33.10

-0.25 (-0.75%)

07/28/17
WEDB
07/28/17
NO CHANGE
WEDB
Outperform
Novocure should be bought on post-earnings pullback, says Wedbush
Wedbush analyst Tao Levy attributes the post-earnings pullback in Novocure to confusion regarding the comparison of the company's reported revenue to the published consensus estimate, but he does not believe it is an "apples-to-apples" comparison. Levy, who said that Optune prescriptions and active patients are "significantly" ahead of expectations, recommends buying the stock on the confusion and keeps an Outperform rating on the shares, which are down 1% in early trading.
09/06/17
MZHO
09/06/17
INITIATION
Target $25
MZHO
Buy
Novocure initiated with a Buy at Mizuho
Mizuho initiated Novocure with a Buy and a $25 price target.
03/26/18
MZHO
03/26/18
NO CHANGE
Target $28
MZHO
Buy
Mizuho 'very positive' on Novocure after management meetings
Mizuho analyst Difei Yang left meetings with Novocure's Executive Chairman Bill Doyle "feeling very positive about the business operation." The analyst expects continued growth in the company's core Glioblastoma business driven by market share gains, potential reimbursement wins from the Centers for Medicare and Medicaid Services and geographic expansion. Further, data readouts from mesothelioma around May/June of this year could provide additional upside to the shares, Yang tells investors in a research note. The analyst reiterates a Buy rating on Novocure with a $28 price target.
04/19/18
DBAB
04/19/18
UPGRADE
Target $29
DBAB
Buy
Novocure upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Gregg Gilbert upgraded Novocure to Buy and raised his price target for the shares to $29 from $19. The analyst says Novocure remains an "under-the-radar oncology story." Following the positive Phase 2 results in mesothelioma, the analyst now assumes a near-term filing and year-end FDA approval of Optune. An approval in the smaller indication could make investors consider Optuneb's potential in the much larger lung and pancreatic cancer setting, Gilbert tells investors in a research note. He sees investor interest in Novocure growing.

TODAY'S FREE FLY STORIES

DISH

Dish

$35.85

0.6 (1.70%)

10:45
09/16/19
09/16
10:45
09/16/19
10:45
Options
Dish call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

WLL

Whiting Petroleum

$10.91

3.38 (44.89%)

, SM

SM Energy

$11.48

1.84 (19.09%)

10:40
09/16/19
09/16
10:40
09/16/19
10:40
On The Fly
Whiting, Parsley seen as stocks to buy in Saudi attack aftermath »

Following an attack on…

WLL

Whiting Petroleum

$10.91

3.38 (44.89%)

SM

SM Energy

$11.48

1.84 (19.09%)

JAG

Jagged Peak Energy

$8.54

1.07 (14.32%)

CDEV

Centennial Resource Development

$5.78

1.37 (31.07%)

PE

Parsley Energy

$20.26

1.78 (9.63%)

SVRGF

Seven Generations Energy

$0.00

(0.00%)

CPG

Crescent Point Energy

$4.59

0.295 (6.87%)

NBR

Nabors Industries

$2.61

0.31 (13.51%)

SLB

Schlumberger

$39.51

2.19 (5.87%)

HAL

Halliburton

$21.73

1.47 (7.26%)

VAL

Valaris

$7.92

1.58 (24.92%)

XOM

Exxon Mobil

$73.69

1.06 (1.46%)

CVX

Chevron

$123.34

1.88 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 25

    Sep

  • 08

    Oct

  • 09

    Oct

  • 18

    Oct

  • 21

    Oct

  • 13

    Nov

AMC

AMC Entertainment

$11.97

(0.00%)

10:35
09/16/19
09/16
10:35
09/16/19
10:35
Options
AMC Entertainment put volume heavy and directionally bearish »

Bearish flow noted in AMC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$218.41

-1.58 (-0.72%)

10:33
09/16/19
09/16
10:33
09/16/19
10:33
Periodicals
Breaking Periodicals news story on Goldman Sachs »

Robin Vince to step down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 15

    Oct

OSTK

Overstock.com

$24.14

-0.69 (-2.78%)

10:30
09/16/19
09/16
10:30
09/16/19
10:30
Periodicals
Patrick Byrne's final act at Overstock crushed short sellers, Bloomberg says »

One of Patrick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$11.42

0.11 (0.97%)

10:29
09/16/19
09/16
10:29
09/16/19
10:29
Conference/Events
Jefferies to hold a bus tour »

Toys & Media Bus Tour…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

WLL

Whiting Petroleum

$10.69

3.16 (41.97%)

10:25
09/16/19
09/16
10:25
09/16/19
10:25
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 09

    Oct

HLUYY

Lundbeck

$0.00

(0.00%)

10:25
09/16/19
09/16
10:25
09/16/19
10:25
Conference/Events
Lundbeck participates in a conference call with JPMorgan »

European Pharma Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLUKY

Lundbeck

$0.00

(0.00%)

10:25
09/16/19
09/16
10:25
09/16/19
10:25
Conference/Events
Lundbeck participates in a conference call with JPMorgan »

Healthcare Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 16

    Sep

DTIL

Precision BioSciences

$10.15

0.385 (3.94%)

10:24
09/16/19
09/16
10:24
09/16/19
10:24
Recommendations
Precision BioSciences analyst commentary  »

Precision IND accepted a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNHI

CNH Industrial

$11.04

-0.16 (-1.43%)

10:22
09/16/19
09/16
10:22
09/16/19
10:22
Hot Stocks
Breaking Hot Stocks news story on CNH Industrial »

CNH Industrial jumps 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNHI

CNH Industrial

$11.04

-0.16 (-1.43%)

10:21
09/16/19
09/16
10:21
09/16/19
10:21
Periodicals
Breaking Periodicals news story on CNH Industrial »

Activist Elliott said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,811.42

-26.07 (-1.42%)

10:20
09/16/19
09/16
10:20
09/16/19
10:20
Periodicals
Amazon plans aggressive expansion of Hub Locker network, CNet reports »

Amazon plans to evaluate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

10:20
09/16/19
09/16
10:20
09/16/19
10:20
General news
Overnight general collateral has surged »

Overnight general…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/16/19
09/16
10:17
09/16/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/16/19
09/16
10:16
09/16/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$42.47

-0.32 (-0.75%)

10:15
09/16/19
09/16
10:15
09/16/19
10:15
Options
International Paper put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PPL

PPL Corp.

$30.67

-0.215 (-0.70%)

10:13
09/16/19
09/16
10:13
09/16/19
10:13
Earnings
PPL Corp. to reaffirm 2019 and 2020 earnings outlooks in meetings »

PPL Corporation disclosed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

AFIN

American Finance Trust

$13.49

0.13 (0.97%)

, IRET

Investors Real Estate

$71.92

0.42 (0.59%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

AFIN

American Finance Trust

$13.49

0.13 (0.97%)

IRET

Investors Real Estate

$71.92

0.42 (0.59%)

APTS

Preferred Apartment

$14.60

0.12 (0.83%)

ENPH

Enphase Energy

$24.07

1.99 (9.01%)

ZM

Zoom Video

$79.31

0.46 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 20

    Sep

  • 30

    Sep

  • 01

    Oct

HAL

Halliburton

$22.12

1.86 (9.18%)

, ACB

Aurora Cannabis

$5.75

-0.195 (-3.28%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

HAL

Halliburton

$22.12

1.86 (9.18%)

ACB

Aurora Cannabis

$5.75

-0.195 (-3.28%)

HPQ

HP Inc.

$18.73

-0.345 (-1.81%)

DKS

Dick's Sporting

$38.93

-0.09 (-0.23%)

JPM

JPMorgan

$119.54

-0.69 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

  • 26

    Sep

  • 15

    Oct

  • 21

    Oct

  • 27

    Oct

  • 13

    Nov

RTN

Raytheon

$202.42

3.6 (1.81%)

, UBER

Uber

$34.50

1.26 (3.79%)

10:12
09/16/19
09/16
10:12
09/16/19
10:12
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

RTN

Raytheon

$202.42

3.6 (1.81%)

UBER

Uber

$34.50

1.26 (3.79%)

LYFT

Lyft

$48.27

2.17 (4.71%)

SLB

Schlumberger

$39.56

2.235 (5.99%)

RMAX

RE/MAX Holdings

$28.19

0.915 (3.35%)

ESPR

Esperion

$36.90

0.34 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

  • 18

    Oct

  • 13

    Nov

SOL

ReneSola

$1.30

0.25 (23.81%)

10:09
09/16/19
09/16
10:09
09/16/19
10:09
Hot Stocks
ReneSola announces intended $11M investment by Shah Capital »

ReneSola announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

ESTA

Establishment Labs

$20.93

(0.00%)

10:08
09/16/19
09/16
10:08
09/16/19
10:08
Hot Stocks
Establishment Labs reports allowance for U.S. patent, 510(k) submission »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

OXY

Occidental Petroleum

$48.44

3.36 (7.45%)

10:05
09/16/19
09/16
10:05
09/16/19
10:05
Options
Occidental Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

DD

DuPont

$72.88

-0.65 (-0.88%)

, RDSMY

DSM

$0.00

(0.00%)

10:04
09/16/19
09/16
10:04
09/16/19
10:04
Periodicals
DSM said to explore bid for DuPont nutrition unit, Bloomberg says »

DSM is said to be among…

DD

DuPont

$72.88

-0.65 (-0.88%)

RDSMY

DSM

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.